BioLife Solutions, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$56.8M
15 notices · 2,239,508 sh
Oct 2025 to Oct 2026
Reported ·
$56.6M
49 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
33 of 49 reported sales carry the 10b5-1 box. Together they are 4.59% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-05-21Casdin Partners Master Fund, L.P., 10% Shareholder$15.6M
2026-05-20Casdin Partners Master Fund, L.P, 10% Shareholder$6,000,000
2026-05-19Casdin Partners Master Fund, L.P., 10% Shareholder$6,690,000
Form 4, 2026-05-21: sold 1,200,000 at $23.44 Form 4 ↗
2026-03-23KAREN FOSTER, Chief Quality and Operations$48,576
Form 4, 2026-03-31: sold 2,577 at $19.17 Form 4 ↗
2026-03-09KAREN FOSTER, Chief Quality and Operations$9,930
2026-03-05KAREN FOSTER, Chief Quality and Operations$2,003,398
Form 4, 2026-03-05: sold 418 at $20.74 Form 4 ↗
2025-12-15SARAH AEBERSOLD, Chief Human Resources Officer$17,390
Form 4, 2026-01-08: sold 241 at $25.59 Form 4 ↗
2025-12-04TROY WICHTERMAN, Chief Financial Officer$771,504
Form 4, 2025-12-05: sold 30,000 at $25.72 Form 4 ↗
2025-11-13RODERICK DE GREEF, President and CEO$789,297
2025-11-12RODERICK DE GREEF, President and CEO$864,995
2025-11-12DuRoss Amy, Director$316,560
Form 4, 2025-11-21: sold 6,000 at $24.76 Form 4 ↗
2025-11-11RODERICK DE GREEF, President and CEO$926,091
Form 4, 2025-11-13: sold 100,000 at $25.80 Form 4 ↗
2025-10-22DE GREEF RODERICK, President and CEO$1,031,807
Form 4, 2025-10-24: sold 37,795 at $27.30 Form 4 ↗
2025-10-16GOSWAMI JOYDEEP, Director$278,910
Form 4, 2025-10-20: sold 1,334 Form 4 ↗